219 related articles for article (PubMed ID: 26299616)
1. Evaluating blood levels of neuron specific enolase, chromogranin A, and circulating tumor cells as Merkel cell carcinoma biomarkers.
Gaiser MR; Daily K; Hoffmann J; Brune M; Enk A; Brownell I
Oncotarget; 2015 Sep; 6(28):26472-82. PubMed ID: 26299616
[TBL] [Abstract][Full Text] [Related]
2. Growth and characterization of a cell line from a human primary neuroendocrine carcinoma of the skin (Merkel cell carcinoma) in culture and as xenograft.
Krasagakis K; Almond-Roesler B; Geilen C; Fimmel S; Krengel S; Chatzaki E; Gravanis A; Orfanos CE
J Cell Physiol; 2001 Jun; 187(3):386-91. PubMed ID: 11319762
[TBL] [Abstract][Full Text] [Related]
3. Differentiation between merkel cell carcinoma and malignant melanoma: An immunohistochemical study.
Kontochristopoulos GJ; Stavropoulos PG; Krasagakis K; Goerdt S; Zouboulis CC
Dermatology; 2000; 201(2):123-6. PubMed ID: 11053914
[TBL] [Abstract][Full Text] [Related]
4. Tumour markers for prediction of survival and monitoring of remission in small cell lung cancer.
Johnson PW; Joel SP; Love S; Butcher M; Pandian MR; Squires L; Wrigley PF; Slevin ML
Br J Cancer; 1993 Apr; 67(4):760-6. PubMed ID: 8385978
[TBL] [Abstract][Full Text] [Related]
5. Differential Outcomes Among Immunosuppressed Patients With Merkel Cell Carcinoma: Impact of Immunosuppression Type on Cancer-specific and Overall Survival.
Cook M; Baker K; Redman M; Lachance K; Nguyen MH; Parvathaneni U; Bhatia S; Nghiem P; Tseng YD
Am J Clin Oncol; 2019 Jan; 42(1):82-88. PubMed ID: 30211723
[TBL] [Abstract][Full Text] [Related]
6. Neuron-specific enolase and chromogranin A as markers of neuroendocrine tumours.
Baudin E; Gigliotti A; Ducreux M; Ropers J; Comoy E; Sabourin JC; Bidart JM; Cailleux AF; Bonacci R; Ruffié P; Schlumberger M
Br J Cancer; 1998 Oct; 78(8):1102-7. PubMed ID: 9792158
[TBL] [Abstract][Full Text] [Related]
7. Merkel cell carcinoma: does tumor size or depth of invasion correlate with recurrence, metastasis, or patient survival?
Sandel HD; Day T; Richardson MS; Scarlett M; Gutman KA
Laryngoscope; 2006 May; 116(5):791-5. PubMed ID: 16652089
[TBL] [Abstract][Full Text] [Related]
8. Predictors of survival and recurrence in the surgical treatment of merkel cell carcinoma of the extremities.
Senchenkov A; Barnes SA; Moran SL
J Surg Oncol; 2007 Mar; 95(3):229-34. PubMed ID: 17323336
[TBL] [Abstract][Full Text] [Related]
9. The prognostic significance of circulating neuroendocrine markers chromogranin a, pro-gastrin-releasing peptide and neuron-specific enolase in patients with advanced non-small-cell lung cancer.
Nisman B; Heching N; Biran H; Barak V; Peretz T
Tumour Biol; 2006; 27(1):8-16. PubMed ID: 16340245
[TBL] [Abstract][Full Text] [Related]
10. Trisomy 6 in Merkel cell carcinoma: a recurrent chromosomal aberration.
Gancberg D; Feoli F; Hamels J; de Saint-Aubain N; André J; Rouas G; Verhest A; Larsimont D
Histopathology; 2000 Nov; 37(5):445-51. PubMed ID: 11119126
[TBL] [Abstract][Full Text] [Related]
11. High levels of antibodies against merkel cell polyomavirus identify a subset of patients with merkel cell carcinoma with better clinical outcome.
Touzé A; Le Bidre E; Laude H; Fleury MJ; Cazal R; Arnold F; Carlotti A; Maubec E; Aubin F; Avril MF; Rozenberg F; Tognon M; Maruani A; Guyetant S; Lorette G; Coursaget P
J Clin Oncol; 2011 Apr; 29(12):1612-9. PubMed ID: 21422439
[TBL] [Abstract][Full Text] [Related]
12. CD56: a useful marker for diagnosing Merkel cell carcinoma.
Kurokawa M; Nabeshima K; Akiyama Y; Maeda S; Nishida T; Nakayama F; Amano M; Ogata K; Setoyama M
J Dermatol Sci; 2003 May; 31(3):219-24. PubMed ID: 12727026
[TBL] [Abstract][Full Text] [Related]
13. Merkel cell carcinoma: a clinicopathological study of 11 cases.
Acebo E; Vidaurrazaga N; Varas C; Burgos-Bretones JJ; Díaz-Pérez JL
J Eur Acad Dermatol Venereol; 2005 Sep; 19(5):546-51. PubMed ID: 16164706
[TBL] [Abstract][Full Text] [Related]
14. Merkel cell carcinoma of the eyelid: histological and immunohistochemical features with special respect to differential diagnosis.
Metz KA; Jacob M; Schmidt U; Steuhl KP; Leder LD
Graefes Arch Clin Exp Ophthalmol; 1998 Aug; 236(8):561-6. PubMed ID: 9717649
[TBL] [Abstract][Full Text] [Related]
15. Merkel cell carcinoma: analysis of clinical, histologic, and immunohistologic features of 132 cases with relation to survival.
Skelton HG; Smith KJ; Hitchcock CL; McCarthy WF; Lupton GP; Graham JH
J Am Acad Dermatol; 1997 Nov; 37(5 Pt 1):734-9. PubMed ID: 9366819
[TBL] [Abstract][Full Text] [Related]
16. Merkel cell carcinoma: squamous and atypical fibroxanthoma-like differentiation in successive local tumor recurrences.
Boutilier R; Desormeau L; Cragg F; Roberts P; Walsh N
Am J Dermatopathol; 2001 Feb; 23(1):46-9. PubMed ID: 11176052
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant local irradiation for Merkel cell carcinoma.
Lewis KG; Weinstock MA; Weaver AL; Otley CC
Arch Dermatol; 2006 Jun; 142(6):693-700. PubMed ID: 16785371
[TBL] [Abstract][Full Text] [Related]
18. Merkel cell carcinoma in the setting of chronic lymphocytic leukemia.
Khezri F; Brewer JD; Weaver AL
Dermatol Surg; 2011 Aug; 37(8):1100-5. PubMed ID: 21631636
[TBL] [Abstract][Full Text] [Related]
19. Merkel cell carcinoma: clinical characteristics, markers, staging and treatment.
Lien MH; Baldwin BT; Thareja SK; Fenske NA
J Drugs Dermatol; 2010 Jul; 9(7):779-84. PubMed ID: 20677532
[TBL] [Abstract][Full Text] [Related]
20. [Merkel cell carcinoma].
Helmbold P; Schröter S; Holzhausen HJ; Dunst J; Marsch WCh
Hautarzt; 2002 Oct; 53(10):652-8. PubMed ID: 12297946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
